Comparing the dissolution rates and pellet fine structure of branded Zovirax® with three similar acyclovir generic products marketed across the world, all containing the same API itraconazole. Raman spectroscopy revealed recrystallizing API slowed the dissolution rate.
It is typical to encounter a restricted number of APIs during the initial stages of drug development. This limitation hinders the swift…
This document provides both a high-level overview of Hycon’s stand-alone small molecule analytical services, and a detailed list of services organized by…
A newly formed pharmaceutical company was creating a novel cardiometabolic drug, a new small molecule, that was in Phase 2a testing in…
Characterizing an API’s different salt forms and polymorphs is an essential drug development task. The successful preclinical assessment and product development can…
Direct-to-Patient Clinical Supply Services: Amid the surge in remote clinical studies, the imperative of facilitating direct-to-patient distribution of clinical supplies has gained…
If scientific literature indicates that elements are not likely to be present in drug product components, and no additional elements are added…